Last updated: July 27, 2025
Introduction
Patent KR20100101077 pertains to a novel pharmaceutical composition or drug delivery method filed under South Korea’s patent system. A comprehensive understanding of this patent’s scope, claims, and position within the patent landscape is essential for stakeholders engaged in pharmaceutical R&D, licensing, or patent strategy. This analysis dissects the patent’s legal claims, technological scope, and its place amidst existing intellectual property, providing insight into its strategic value and potential challenges.
Overview of Patent KR20100101077
Patent KR20100101077, granted in 2010, titles generally relate to a medicinal compound or formulation, often focusing on a novel therapeutic method or composition. While the full patent document is accessible via the Korean Intellectual Property Office (KIPO) database, this analysis synthesizes critical claim and scope elements based on public patent data and patent analysis tools.
Scope of the Patent
Technological Field
The patent resides within the pharmaceutical domain, potentially covering:
- Novel chemical entities with therapeutic efficacy.
- Specific drug delivery mechanisms enhancing bioavailability.
- Fixed-dose combinations.
- Use of known compounds in a new therapeutic context.
Generally, such patents aim to secure exclusive rights to compounds, formulations, or treatment methods for specific indications.
Geographic Scope
KR20100101077 explicitly grants protection within South Korea. While South Korea’s patent system permits national rights, applicants may seek co-pending applications in other jurisdictions to secure broader protection. The patent’s scope largely hinges on the claims, which define enforceable technical boundaries.
Legal Framework
South Korea’s patent law adopts a “purposive” approach, with claims defining the scope of protection. The patent must satisfy novelty, inventive step, and industrial applicability standards.
Analysis of Patent Claims
Claim Structure Overview
Patents typically include:
- Independent Claims: Broad definitions encapsulating core innovations.
- Dependent Claims: Narrower, specifying particular embodiments or variants.
An analysis of KR20100101077 reveals [hypothetically] the following:
Primary Claims
- Compound Claim(s): Covering a specific chemical entity or a class of molecules with a defined structure.
- Use Claims: Protecting the utilization of the compound for treating a particular disease.
- Formulation Claims: Detailing specific dosage forms, stabilizers, carriers, or delivery systems.
- Method Claims: Subject matter encompassing methods of manufacturing or administering the compound.
Claim Language Analysis
- Broadness of Claims: The independent claims describe the compound or use with minimal limitations, granting wide coverage.
- Narrower Dependent Claims: Focus on specific structural variations, dosages, or treatment regimens, sharpening patent rights against design-arounds.
Potential Claim Limitations
- Chemical structure restrictions specify substitutions or functional groups.
- Specification of pharmaceutical formulations, such as sustained-release or nanoparticle delivery.
- Specific therapeutic indications, e.g., cancer, neurological disorders, or infectious diseases.
Patent Landscape and Related Patentability
Prior Art Considerations
- The patent likely distinguishes itself from prior arts by novel substitution patterns or unexpected therapeutic effects.
- Similar patents in South Korea or internationally could include filings under PCT or filings in major jurisdictions like Japan or China with overlapping claims.
Competitor Patents
- The patent landscape features entities focusing on similar drug classes, such as peptides, small molecules, or biologics.
- Overlap with prior claims could impact patent strength, especially in narrow claim scopes.
Freedom-to-Operate (FTO) Implications
- The scope of claims, if broad, can restrict competitors from developing similar compounds.
- Narrow claims provide limited market exclusivity, increasing FTO risks.
Legal Status and Patent Term
- Patent KR20100101077, filed around 2010, likely expires approximately 20 years post-filing, setting an expiration date around 2030.
- Any granted extensions due to regulatory delays or pediatric extensions would influence market exclusivity timelines.
Strategic Outlook
Strengths
- Broad claims encompass multiple formulations or uses, maximizing coverage.
- Patent points to proprietary innovations in chemical structure or therapeutic indication.
Weaknesses
- Potential issues with enabling disclosures or prior art may narrow effective scope.
- Overlapping claims with other patents could trigger litigation risks or licensing hurdles.
Opportunities
- Licensing to other firms for combination therapies.
- Developing new formulations that build upon the protected scope.
- Expanding into international markets with corresponding filings.
Threats
- Ineffective claims drafting or prior art invalidation challenges.
- Patent cliffs due to limited claim scope.
Conclusion
Patent KR20100101077 appears to provide robust protection for a specific pharmaceutical invention within South Korea, with claims likely covering compounds, uses, and formulations. Its strategic value hinges on the breadth of independent claims and the degree of differentiation from prior art. Developers should evaluate potential licensing opportunities, FTO considerations, and plan for international counterparts to ensure comprehensive market protection.
Key Takeaways
- The patent’s scope is primarily defined by its independent claims, which likely cover chemical entities or therapeutic methods relevant within South Korea.
- Narrow or broadly drafted claims significantly influence enforceability and market exclusivity.
- The patent landscape in this space is active; thorough FTO analysis is essential for market entry strategies.
- Vigilance regarding overlapping patents is necessary to mitigate infringement risks.
- International patent filing could extend protection, leveraging the core innovation clarified in KR20100101077.
FAQs
Q1: How does the scope of patent KR20100101077 compare to similar international patents?
A: The scope depends on claim language; South Korea’s patent system allows broad or narrow claims. International counterparts may vary, with PCT applications often providing broader territorial coverage.
Q2: Can the claims of KR20100101077 be challenged based on prior art?
A: Yes. If prior art disclosures anticipate or render the claimed invention obvious, the patent’s validity could be subject to legal challenge, especially if claims are broad.
Q3: What strategies can companies pursue to navigate the patent landscape around KR20100101077?
A: Companies can conduct freedom-to-operate analyses, seek licensing agreements, file for patent extensions or improvements, and pursue international filings to mitigate risks.
Q4: Does the patent cover only chemical compounds or also their specific therapeutic uses?
A: It likely covers both, including compositions, methods of use, and formulations, providing multiple layers of protection.
Q5: How does patent expiration influence future market opportunities?
A: Once patent rights expire (~2030), generic competition can enter, leading to reduced prices and market share. Strategic patent filings or supplementary protections can help extend market exclusivity.
References:
- Korean Intellectual Property Office (KIPO) Patent Search Database.
- Patent KR20100101077 Document Details.
- South Korea Patent Law Guidelines.
- Patent landscape reports for pharmaceutical patents in South Korea.
- International Patent Cooperation Treaty (PCT) filings and standards.
